<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4d67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="16" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font11" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font13" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font14" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font16" size="10" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font17" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font18" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font19" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font20" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font21" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font22" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="508" width="46" height="10" font="font4" id="p1_t2" reading_order_no="60" segment_no="23" tag_type="text">Page 1 of 5<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="61" segment_no="24" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="35" left="55" width="312" height="23" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">Microbial Cell Factories</text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Open Access<i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="50" height="13" font="font8" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="title">Research<b>Microbial Cell Factories</b></text>
<text top="105" left="55" width="499" height="15" font="font9" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="title">Use of pIVEX plasmids for protein overproduction in Escherichia coli<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="122" left="55" width="229" height="14" font="font11" id="p1_t8" reading_order_no="5" segment_no="5" tag_type="text">Julie Rogé and Jean-Michel Betton*</text>
<text top="158" left="55" width="488" height="8" font="font12" id="p1_t9" reading_order_no="6" segment_no="6" tag_type="text">Address: Unité de Repliement et Modélisation des Protéines Institut Pasteur CNRS-URA2185 28, rue du Docteur Roux 75724 Paris Cedex 15,<b>Use of pIVEX plasmids for protein overproduction in </b></text>
<text top="167" left="55" width="23" height="8" font="font12" id="p1_t10" reading_order_no="7" segment_no="6" tag_type="text">France<i><b>Escherichia coli</b></i></text>
<text top="182" left="55" width="302" height="8" font="font12" id="p1_t11" reading_order_no="8" segment_no="7" tag_type="text">Email: Julie Rogé - jroge.abag@wanadoo.fr; Jean-Michel Betton* - jmbetton@pasteur.fr</text>
<text top="193" left="55" width="92" height="8" font="font12" id="p1_t12" reading_order_no="9" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="341" left="112" width="44" height="10" font="font13" id="p1_t13" reading_order_no="19" segment_no="16" tag_type="title">Abstract</text>
<text top="356" left="112" width="385" height="9" font="font14" id="p1_t14" reading_order_no="20" segment_no="17" tag_type="text">Background: The pIVEX plasmids are vectors optimized for expression in the Rapid Translation</text>
<text top="368" left="112" width="386" height="9" font="font15" id="p1_t15" reading_order_no="21" segment_no="17" tag_type="text">System (RTS) cell-free system under control of bacteriophage T7 transcription elements. Even if<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15932643">  </a></text>
<text top="380" left="112" width="386" height="9" font="font15" id="p1_t16" reading_order_no="22" segment_no="17" tag_type="text">these plasmids are intended for use in vitro , it is usually worthwhile to compare both cell-free and<b>Abstract</b></text>
<text top="391" left="112" width="386" height="9" font="font15" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">bacterial expression from the same genetic construct. However, some RTS users encountered<b>Background: </b></text>
<text top="403" left="112" width="386" height="9" font="font15" id="p1_t18" reading_order_no="24" segment_no="17" tag_type="text">problems when they introcuded these plasmids into Escherichia coli host strains producing the T7</text>
<text top="415" left="112" width="70" height="9" font="font15" id="p1_t19" reading_order_no="25" segment_no="17" tag_type="text">RNA polymerase.</text>
<text top="428" left="112" width="385" height="13" font="font14" id="p1_t20" reading_order_no="26" segment_no="18" tag_type="text">Results: We verified that difficulties in transforming the commonly used BL21( λ DE3) strain with</text>
<text top="443" left="112" width="386" height="9" font="font15" id="p1_t21" reading_order_no="27" segment_no="18" tag_type="text">pIVEX arose from the presence of a strong T7 promoter combined with a high-copy number<i>in vitro</i></text>
<text top="455" left="112" width="386" height="9" font="font15" id="p1_t22" reading_order_no="28" segment_no="18" tag_type="text">plasmid, independent of gene expression. When these vectors were introduced into this strain</text>
<text top="467" left="112" width="385" height="9" font="font15" id="p1_t23" reading_order_no="29" segment_no="18" tag_type="text">harboring a compatible plasmid carrying the lactose repressor ( lacI ), we improved the</text>
<text top="479" left="112" width="386" height="9" font="font15" id="p1_t24" reading_order_no="30" segment_no="18" tag_type="text">transformation efficiency by 4 orders of magnitude. Moreover, we designed a transformation</text>
<text top="490" left="112" width="386" height="9" font="font15" id="p1_t25" reading_order_no="31" segment_no="18" tag_type="text">protocol that allows, after induction, the overproduction of pIVEX-encoded proteins in the<i>Escherichia coli </i></text>
<text top="499" left="112" width="75" height="13" font="font15" id="p1_t26" reading_order_no="32" segment_no="18" tag_type="text">BL21( λ DE3) strain.</text>
<text top="519" left="112" width="385" height="9" font="font14" id="p1_t27" reading_order_no="33" segment_no="19" tag_type="text">Conclusion: Using the correct plasmid/host combination and transformation-expression</text>
<text top="531" left="112" width="386" height="9" font="font15" id="p1_t28" reading_order_no="34" segment_no="19" tag_type="text">protocol, we could directly compare overproduction of the same pIVEX-encoded proteins from<b>Results: </b></text>
<text top="542" left="112" width="168" height="9" font="font15" id="p1_t29" reading_order_no="35" segment_no="19" tag_type="text">both in vivo and in vitro expression systems.</text>
<text top="592" left="55" width="60" height="10" font="font13" id="p1_t30" reading_order_no="36" segment_no="20" tag_type="title">Background</text>
<text top="603" left="55" width="241" height="9" font="font18" id="p1_t31" reading_order_no="37" segment_no="22" tag_type="text">Recent developments in cell-free systems offer new and</text>
<text top="615" left="55" width="241" height="9" font="font18" id="p1_t32" reading_order_no="38" segment_no="22" tag_type="text">promising possibilities for producing recombinant pro-</text>
<text top="627" left="55" width="241" height="9" font="font18" id="p1_t33" reading_order_no="39" segment_no="22" tag_type="text">teins [1]. The RTS, commercialized by Roche, is an</text>
<text top="638" left="55" width="241" height="9" font="font18" id="p1_t34" reading_order_no="40" segment_no="22" tag_type="text">exchange cell-free system with improved productivity [2].</text>
<text top="650" left="55" width="241" height="9" font="font18" id="p1_t35" reading_order_no="41" segment_no="22" tag_type="text">The continuous supply of consumable substrates and<i>lacI</i></text>
<text top="662" left="55" width="241" height="9" font="font18" id="p1_t36" reading_order_no="42" segment_no="22" tag_type="text">removal of reaction products provide a yield of several</text>
<text top="674" left="55" width="241" height="9" font="font18" id="p1_t37" reading_order_no="43" segment_no="22" tag_type="text">milligrams of protein. This system uses bacteriophage T7</text>
<text top="686" left="55" width="241" height="9" font="font18" id="p1_t38" reading_order_no="44" segment_no="22" tag_type="text">RNA polymerase to perform transcription, while an</text>
<text top="697" left="55" width="241" height="9" font="font18" id="p1_t39" reading_order_no="45" segment_no="22" tag_type="text">enriched E. coli S30 extract provides the translational</text>
<text top="709" left="55" width="241" height="9" font="font18" id="p1_t40" reading_order_no="46" segment_no="22" tag_type="text">machinery. Thus, protein production in RTS requires a</text>
<text top="721" left="55" width="241" height="9" font="font18" id="p1_t41" reading_order_no="47" segment_no="22" tag_type="text">preliminary cloning step of the target gene into a vector,</text>
<text top="592" left="313" width="241" height="9" font="font18" id="p1_t42" reading_order_no="48" segment_no="21" tag_type="text">downstream of the T7 promoter. For this purpose, the<b>Conclusion: </b></text>
<text top="603" left="313" width="241" height="9" font="font18" id="p1_t43" reading_order_no="49" segment_no="21" tag_type="text">pIVEX family of expression plasmids has been optimized</text>
<text top="615" left="313" width="241" height="9" font="font18" id="p1_t44" reading_order_no="50" segment_no="21" tag_type="text">for in vitro use. They include a T7 promoter comprising the</text>
<text top="627" left="313" width="241" height="9" font="font18" id="p1_t45" reading_order_no="51" segment_no="21" tag_type="text">T7 gene 10 translation enhancer [3], an efficient prokary-</text>
<text top="638" left="313" width="241" height="9" font="font18" id="p1_t46" reading_order_no="52" segment_no="21" tag_type="text">otic Shine-Dalgarno sequence with an optimum distance<i>in vivo </i></text>
<text top="650" left="313" width="241" height="9" font="font18" id="p1_t47" reading_order_no="53" segment_no="21" tag_type="text">to the start codon, a multiple cloning site, and a T7 termi-</text>
<text top="662" left="313" width="241" height="9" font="font18" id="p1_t48" reading_order_no="54" segment_no="21" tag_type="text">nator which prevents 3'-terminal exonucleolytic degrada-<i>in vitro </i></text>
<text top="674" left="313" width="241" height="9" font="font18" id="p1_t49" reading_order_no="55" segment_no="21" tag_type="text">tion of the mRNA. These vectors are very convenient since</text>
<text top="686" left="313" width="241" height="9" font="font18" id="p1_t50" reading_order_no="56" segment_no="21" tag_type="text">multiple cloning sites were designed to allow gene fusions<b>Background</b></text>
<text top="697" left="313" width="241" height="9" font="font18" id="p1_t51" reading_order_no="57" segment_no="21" tag_type="text">with several tags either at the N- or C-terminal of target</text>
<text top="709" left="313" width="241" height="9" font="font18" id="p1_t52" reading_order_no="58" segment_no="21" tag_type="text">proteins by conserving the same restriction strategy and</text>
<text top="721" left="313" width="120" height="9" font="font18" id="p1_t53" reading_order_no="59" segment_no="21" tag_type="text">reading frame compatibility.<a href="">1</a>]. The RTS, commercialized by Roche, is an</text>
<text top="236" left="55" width="77" height="7" font="font20" id="p1_t54" reading_order_no="10" segment_no="9" tag_type="text">Published: 02 June 2005<a href="">ctivity [2].</a></text>
<text top="250" left="55" width="106" height="7" font="font21" id="p1_t55" reading_order_no="11" segment_no="12" tag_type="text">Microbial Cell Factories 2005, 4 :18</text>
<text top="250" left="170" width="92" height="7" font="font20" id="p1_t56" reading_order_no="12" segment_no="12" tag_type="text">doi:10.1186/1475-2859-4-18</text>
<text top="236" left="310" width="78" height="7" font="font20" id="p1_t57" reading_order_no="17" segment_no="10" tag_type="text">Received: 21 April 2005</text>
<text top="245" left="310" width="77" height="7" font="font20" id="p1_t58" reading_order_no="18" segment_no="11" tag_type="text">Accepted: 02 June 2005</text>
<text top="264" left="55" width="267" height="7" font="font20" id="p1_t59" reading_order_no="13" segment_no="13" tag_type="text">This article is available from: http://www.microbialcellfactories.com/content/4/1/18</text>
<text top="279" left="55" width="181" height="7" font="font20" id="p1_t60" reading_order_no="14" segment_no="14" tag_type="text">© 2005 Rogé and Betton; licensee BioMed Central Ltd.<i>E. coli </i></text>
<text top="288" left="55" width="492" height="7" font="font20" id="p1_t61" reading_order_no="15" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),</text>
<text top="297" left="55" width="400" height="7" font="font20" id="p1_t62" reading_order_no="16" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
